openPR Logo
Press release

Global OTC Pediatric Healthcare Market: Brief Analysis of Products and Application Set to Attain Higher Position Through 2022

07-05-2018 07:41 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

According to the latest report by Fact.MR, the global market for OTC pediatric healthcare is anticipated to reach close to US$ 10,000 million revenue by 2022 end. The market is expected to experience sluggish growth during the forecast period, 2017 to 2022. Increasing risk of serious side-effects due to OTC medicines based on self-care decision is restricting the parents from choosing OTC drugs for children, thus leading to the decline in OTC pediatric healthcare.

4 Forecast Highlights on Global OTC Pediatric Healthcare Market

1. Among all the other regions, North America is anticipated to surpass US$ 2,000 million revenue by the end of 2022. Increasing consumer awareness to treat minor health issues among children due to a various initiative by the government such as campaign, awareness drive, etc., is one of the factors driving the growth of OTC drugs in the region.

2. Japan and the Middle East and Africa (MEA) are expected to be the least growing market in OTC pediatric healthcare during 2017-2022.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=257

3. Dermatology OTC pediatric products are anticipated to reach close to US$ 3,500 million towards the end of 2022. Global sales of Dermatology OTC pediatric products is expected to gain around one-third revenue share on the global revenues by the end of 2017.

4. Sales of OTC pediatric products will be highest through drug stores/ pharmacies. By the end of 2017, drug stores/pharmacies are expected to account for nearly one-third of the revenue share of the global revenues. Meanwhile, sales of OTC pediatric products will be the least through convenience stores.

High Sales through Drug Stores/ Pharmacies

Accounting for nearly one-third of revenue share in the OTC pediatric healthcare, drug stores/ Pharmacies emerge as one of the most lucrative sales channels. Towards the end of 2022, drug stores/ pharmacies are projected to reach close to US$ 3,200 million revenues. Although, global sales of OTC pediatric medicines through hospital pharmacies is projected to create an incremental opportunity of over US$ 300 million during 2017-2022.

Dermatology- Top-Selling Product

OTC pediatric medicines that fall under dermatology are projected to remain top-selling products in the global OTC pediatric healthcare market between 2017 and 2022. Sale of Dermatology OTC pediatric drugs is expected to bring in nearly US$ 3,500 million revenues towards the end of 2022. Meanwhile, ENT OTC pediatric medicines are anticipated to account for lowest revenue shares. OTC cold and cough medicines are not recommended for children because of the risk of serious side-effects and high chances of developing breathing problems.

Browse Full Report with TOC- https://www.factmr.com/report/257/otc-pediatric-healthcare-market

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global OTC pediatric healthcare market through 2022, which include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer Aktiengesellschaft, Sanofi, Pfizer, Inc., Reckitt Benckiser Group plc, and Church & Dwight Co., Inc.

Table of Contents:

1. Global OTC Pediatric Healthcare Market – Executive Summary

2. Global OTC Pediatric Healthcare Market Overview

3. Global OTC Pediatric Healthcare Market Analysis and Forecast By Product Type

4. Global OTC Pediatric Healthcare Market Analysis and Forecast By Sales Channel
4.1. Global OTC Pediatric Healthcare Market Size and Forecast By Sales Channel, 2012-2022
4.1.1. Drug store/ Pharmacy OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Hospital Pharmacies OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region

5. Global OTC Pediatric Healthcare Market Analysis and Forecast By Region
5.1. Global OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
5.1.1. North America OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.1.2. Revenue (US$ Mn) Comparison, By Sales Channel

Buy this Report- https://www.factmr.com/checkout/257/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global OTC Pediatric Healthcare Market: Brief Analysis of Products and Application Set to Attain Higher Position Through 2022 here

News-ID: 1110588 • Views:

More Releases from Fact.MR

Liquid Biopsy Market to Hit USD 24.70 Billion by 2033 | Key Players Covered: Bio-Rad Laboratories, Biocept Inc, Guardant Health, Illumina Inc, F. Hoffman-La Roche Ltd, Johnson & Johnson
09-04-2025 | Health & Medicine
Fact.MR
Liquid Biopsy Market to Hit USD 24.70 Billion by 2033 | Key Players Covered: Bio …
The global liquid biopsy market size is estimated at US$ 4.72 billion in 2023 and is forecasted to expand rapidly at a CAGR of 18% to reach a valuation of US$ 24.70 billion by 2033, according to a newly released market study of liquid biopsy by Fact.MR, a market research and competitive intelligence provider. This growth is driven by the increasing demand for non-invasive cancer diagnostics, advancements in next-generation sequencing
Artificial Kidney Market is Growing at a CAGR of 13% by 2033 | Key Players: Kawasumi Laboratories Inc., Nanodialysis B.V, Fresenius SE & Co KGaA, Baxter, Asahi Kasei Medical
09-04-2025 | Health & Medicine
Fact.MR
Artificial Kidney Market is Growing at a CAGR of 13% by 2033 | Key Players: Kawa …
Artificial Kidney Market is valued at USD 1.5 billion in 2023 and is projected to surge ahead at a CAGR of 13% to reach a market size of USD 5.3 billion by the end of 2033. This robust growth is driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), affecting millions worldwide, and the limitations of current dialysis treatments. Artificial kidneys, including wearable and
Artificial Intelligence (AI) in Retail Market is Projected to Reach USD 138.3 Billion by 2035 | Fact.MR Analysis
Artificial Intelligence (AI) in Retail Market is Projected to Reach USD 138.3 Bi …
The global artificial intelligence (AI) in retail market is forecast to reach USD 138.3 billion by 2035, up from USD 9.8 billion in 2025. During the forecast period, the industry is projected to register at a CAGR of 30.3%. AI-driven personalization enhances customer engagement through tailored recommendations and experiences. AI-powered demand forecasting optimizes inventory management and reduces operational inefficiencies. This rapid expansion is fueled by the increasing adoption of AI
Mining Automation Market is Expected to Reach USD 8.4 Billion by 2035 | Fact.MR Report
Mining Automation Market is Expected to Reach USD 8.4 Billion by 2035 | Fact.MR …
The global mining automation market is forecast to reach USD 8.4 billion by 2035, up from USD 4.5 billion in 2025. During the forecast period, the industry is projected to register at a CAGR of 6.4%. This growth is driven by the increasing demand for minerals, the need for sustainable and low-emission operations, labor shortages, and enhanced safety in hazardous environments. Technological advancements in AI, IoT, robotics, and digital twins

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to